newsfilter
← Latest News
GlobeNewswire·

Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 Million

EWING, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced guidance for full-year 2021 and expects...